Status:
COMPLETED
NEUROFEEDSTIM : Therapeutic Use of Neurofeedback in Depression in Association With TMS
Lead Sponsor:
Rennes University Hospital
Conditions:
Depression
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Neurofeedback is an increasingly researched technique for the treatment of many psychological disorders, such as attention deficit / hyperactivity disorder (AD / HD), depression, or substance abuse. T...
Detailed Description
Primary objective : To demonstrate a decrease in the intensity of depressive symptomatology following EEG-neurofeedback training in association with TMS and see if there is a correlation with a change...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patient with a major depressive episode (DSM IV-TR 296) with an indication of TMS (whether or not they have previously benefited from TMS);
- Aged 18 and over;
- With a score greater than or equal to 15 at the MADRS;
- Under stable and unchanged pharmacological treatment for at least one month;
- Having signed a free and informed consent to participate in the study.
- Non inclusion Criteria:
- Other psychiatric disorder of axis 1 of DSM IV-TR (schizophrenia, substance abuse / dependence, ...);
- Neurological or dementia history according to DSM criteria;
- Pregnant or nursing women;
- Major persons subject to legal protection (safeguard of justice, curators, guardianship);
- Participation in another research involving the human interventionist or at risk and minimal constraints
- Confined hospitalized patients (SDT, SDRE).
Exclusion
Key Trial Info
Start Date :
December 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 7 2019
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03279913
Start Date
December 18 2017
End Date
September 7 2019
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Guillaume Régnier
Rennes, Britanny, France, 35000